• 제목/요약/키워드: Korean pharmaceutical codex

검색결과 18건 처리시간 0.019초

우라자미드 정의 유해시약 대체 시험법의 개발 (Development of Alternative Assay Method without Hazardous Reagent, Chloroform for Urazamide Tablets in Korean Pharmaceutical Codex)

  • 이유림;김현지;서나래;김경호
    • 약학회지
    • /
    • 제58권2호
    • /
    • pp.125-128
    • /
    • 2014
  • We developed an alternative assay method without hazardous reagent of chloroform for urazamide tablets in Korean Pharmaceutical Codex. The HPLC analytical method was validated by system suitability, linearity, precision, accuracy and robustness. The linearity of the calibration curves in the desired concentration range is good ($r^2$ >0.999). Precision was obtained less than RSD 1.17%. Accuracy was obtained with recoveries in range of 98.12% and 99.47%. The developed assay could be expected to become valuable tools for revising the Korean Pharmaceutical Codex.

디페메린염산염 시험에 사용되는 유해시약인 수은 대체 시험법의 개발 (Development of alternative titration method without mercuric acetate for the assay of difemerine hydrochloride in Korean Pharmaceutical Codex)

  • 전상설;김경호
    • 분석과학
    • /
    • 제27권4호
    • /
    • pp.196-200
    • /
    • 2014
  • 국가 공정서 중 하나인 대한민국약전외의약품 기준에는 디페메린염산염의 정량법으로 유해시약인 아세트산수은을 사용하는 비수적정법이 수재되어 있다. 본 연구에서는 디페메린염산염의 환경 친화적인 대체 시험법으로 보다 안전하고 효율적인 친환경용매인 에탄올을 사용하는 중화적정법을 개발하고, 분석법을 검증하였다. 디페메린염산염의 직선성은 상관계수(r)가 0.999 이상을 나타내었고, 정확도는 99.10~99.71%, 정밀도는 0.64% 이하로 나타났다. 개발된 시험법은 대한민국약전외의약품 기준의 개정에 기여가 될 것이다.

고시의약품 시험에 사용되는 유해시약 대체 시험법 개발 (Development of Alternative Testing Methods without Hazardous Reagents used in Korean Pharmaceutical Codex)

  • 김희연;강현경;최선희;방수진;한경진;최승희;김진희;이화정;강찬순
    • 약학회지
    • /
    • 제54권2호
    • /
    • pp.142-149
    • /
    • 2010
  • Development of alternative testing methods for the replacement of hazardous reagents with less hazardous ones is strongly enforced because exposure of human and environment to hazardous reagents are restricted and hazardous reagents are gradually prohibited from using in various testing methods. Thus, in this study, we developed 8 monographs from the Korean Pharmaceutical Codex by substituting the use of the hazardous reagents including ICH class 1 such as benzene, chloroform and dioxane to the use of less toxic ones like ICH class 2 or 3 reagents. We also improved their qualification and quantification performance. Among 8 monographs, the 6 newly developed TLC methods for the identification of nifedipine, oxolamine citrate, ketoprofen lysinate, chlorquinaldol, retinol acetate, and riboflavin showed a clear spot of corresponding material without any interference in spite of the replacement with ICH class 2 or 3 reagents. For the quantification of domperidone and trimebutine, HPLC methods were developed for the substitution of UV/VIS spectrometry and titrimetry, respectively. These HPLC methods were validated for the linearity, recovery, reproducibility, and inter-laboratory variations. In conclusion, the newly developed methods could be expected to become valuable tools for revising the Korean Pharmaceutical Codex.

공정서 수재 의약품의 정량법 개선에 관한 연구 (Establishment of Quantitative Method for Generic Drugs in Korea Pharmaceutical Codex Monograph)

  • 송재용;장진섭;장승은;김선회;김인규;이길봉;이제만;김용희
    • 약학회지
    • /
    • 제56권5호
    • /
    • pp.288-292
    • /
    • 2012
  • The aim of the paper is to ameliorate old research methods of Korean Pharmaceutical Codex to adjust the newest scientistic level which is necessary to maintain quality of medical supplies effectively. After reviewing result of Establishment of Dissolution Specifications for Generic Drugs in Korea Pharmaceutical Codex Monograph, there are two items chosen for the methods - Establishment of Dissolution Specifications for Generic Drugs in Korea Pharmaceutical Codex Monograph which KFDA researched in 2010, arranged new measuring standard by having an experiment to set measuring method after obtaining each item. According to the result, The experiment includes a measuring method of two items; Nafronyl Oxalate Capsules, and Ticlopidine Hydrochloride Tablets. The research is ameliorated by research methods through several experiments such as High Performance Liquid Chromatography validation, preparing items, implement of trial-experiment and authentic experiment, and experiment on measuring method of regulations of Korea Pharmaceutical Codex. The experiments are taken opinions of experts in KFDA into consideration and wrote out a report of the new measuring method on each last item. The report is combined as each two experiment sections of analyzing method to maintain the quality on the basis of the research in 2010 on setting of dissolution specifications for oral solid dosage forms. The result of measuring method of medical supplies through modernizing trial method of oral solid dosage forms is available to be accurate. In conclusion, this study could contribute to promotion of public health by organizing a basis for safe and high quality of medical supplies in domestic market.

복방서양산사60%에탄올엑스.은행엽엑스.마늘유캡슐의 기준 및 시험법과 규격 설정 (Development of the Standard Analytical Methods for Compound Hawthorn Berry 60% Ethanol Extract, Ginkgo Biloba Leaf Extract and Garlic Oil Capsules)

  • 조창희;김지선;황지상;백주현;박주영;심영훈;성락선;김동섭;이종필;이주헌;손수정
    • 생약학회지
    • /
    • 제41권1호
    • /
    • pp.67-72
    • /
    • 2010
  • In the recent version of the Korea Pharmacopoeia(KP) and the Korean Herbal Pharmacopoeia(KHP), there are 563 items(181 in KP, 381 in KHP) of herbal medicines including finished drugs. Also, approximately 507 items including herbal extracts and herbal medicinal products was published in the 3th edition of Korea Pharmaceutical Codex (KPC). These items help the persons working in the pharmaceutical manufacturing field to register the drug and in research fields to develop the new drug considering as a standard specifications. This study was carried out to establish standard analytical methods for 'Compound Hawthorn Berry 60% Ethanol Extract, Ginkgo Biloba Leaf Extract and Garlic Oil Capsules' in the 3th edition of Korea Pharmaceutical Codex. Ginkgo flavonoid and terpene lactone were employed as reference compounds for analytical method. Analytical methods established in this study could be applied to a reasonable and unified quality control of G. biloba leaf extract and hawthorn berry extract.

세프록사딘 캡슐 시험에 사용되는 유해시약인 사염화탄소 대체 공정시험법 개발 (Development of alternative assay method without hazardous reagent, carbon tetrachloride, for cefroxadine capsules in Korean Pharmaceutical Codex)

  • 서나래;강여울;박영신;이종민;정명진;전상설;안재형;김경호
    • 분석과학
    • /
    • 제27권3호
    • /
    • pp.161-166
    • /
    • 2014
  • 국가공정서 중 하나인 대한민국약전외의약품기준에는 세프록사딘 캡슐의 정량법으로 유해시약인 사염화탄소를 사용하는 산화환원분석법이 수재되어 있다. 세프록사딘 캡슐의 환경 친화적인 대체 시험법으로 보다 안전하고 효율적인 친환경용매를 사용하는 HPLC 분석법을 개발하고, 이를 검증하였다. 직선성은 상관계수($r^2$)가 0.999이상으로 우수하였다. 일내 정밀도는 상대표준편차 0.30~0.69%, 일간 정밀도는 0.47~0.82%로, 회수율은 100.20~100.56%로 나타났다. 개발한 시험법을 이용하여 시중 유통 중인 세프록사딘 캡슐 중 세프록사딘의 함량측정에 응용하였다. 개발된 시험법은 대한민국약전외의약품기준의 개정에 기여가 될 것이다.

의약품 등 기준 및 시험방법(제 3개정) 소개 (Revision of The Korean Pharmceutical Codex, The Third Edition)

  • 최명신;양지선;유태무;김인규;김혜수;이선희;장승엽;조정희;이수정;김영림;김미정;김은정;이종필;김도훈;백경민;김희성;박상애;강인호;김은경
    • Journal of Pharmaceutical Investigation
    • /
    • 제35권3호
    • /
    • pp.201-205
    • /
    • 2005
  • The aim of publishing the Korean Pharmaceutical Codex is to update and set specification of essential drugs for humane health. In accordance with speedy development of new drugs and improvement of science and technology, the need of revision of drug specification through the ICH guidelines and discussions between regulatory agency and pharmaceutical industry for the quality assurance of safer and efficient drugs is getting higher. The first edition of Korean Pharmaceutical Codex was published in 1983. Now, the third revision of the Codex is prepared because of the revision of domestic and foreign Pharmacopeias, changes of drug control environment, improvement of science and technology and so on. The aim of 3th edition is to improve the quality of essential drugs through the setting of the required specifications and discussions between the regulatory agency and pharmaceutical industry.

고시수재 의약품 중 암브록솔염산염 및 클렌부테롤염산염 함유 제제의 함량 시험법 개선 (Development of Analytical Method for Ambroxol Hydrochloride and Clenbuterol Hydrochloride Formulation in Korean Pharmaceutical Codex)

  • 이태웅;정래석;박수진;최란;심영훈;최보경;곽효선
    • 약학회지
    • /
    • 제58권3호
    • /
    • pp.190-199
    • /
    • 2014
  • The Korean Pharmaceutical Codex (KPC) analytical method of ambroxol hydrochloride and clenbuterol hydrochloride formulation is complicated and needed to carry out multiple processes during the test. To improve the low efficiency of analytical procedure that makes pharmaceutical laboratory consume much time and high cost to conduct the test of this formulation, this study was performed for simplifying the pretreatment process and optimizing conditions of the HPLC assay. The analytical procedure using HPLC was developed to establish analytical specification for ambroxol hydrochloride and clenbuterol hydrochloride formulations. The newly developed analytical method has good linearity ($R^2$ >0.999), specificity, precision (RSD<1.0%) and the recovery ranges of 98.50~101.84% for ambroxol, 98.29~101.35% for clenbuterol syrup and 98.66~101.71% for clenbuterol tablets. The LOQs were 0.204 ${\mu}g/ml$ for ambroxol, 0.021 ${\mu}g/ml$ for clenbuterol syrup and 0.073 ${\mu}g/ml$ for clenbuterol tablets. The new method was performed with commercially available samples to confirm analytical conditions and validated to be suitable for saving time and cost to control the quality of routine manufactured products. This analytical method will be used for revising the monograph of ambroxol hydrochloride and clenbuterol hydrochloride formulation in next supplement of KPC.

고시수재 의약품 중 아세브로필린 캡슐 및 브롬헥신염산염 정의 용출시험법 개발 (Development of Dissolution Test Method for Acebrophylline Capsules and Bromhexine Hydrochloride Tablets in Korean Pharmaceutical Codex)

  • 이태웅;정래석;정승아;김정현;심영훈;김인규;박창원
    • 약학회지
    • /
    • 제57권3호
    • /
    • pp.226-233
    • /
    • 2013
  • Although the dissolution test can serve as an effective tool for quality control and predictor of in vivo performance, there are a number of drugs with no established dissolution specification in Korean Pharmaceutical Codex (KPC). So, with each reference and test drugs, the dissolution test method and an analytical procedure by HPLC were developed and validated to establish dissolution specification for acebrophylline capsules and bromhexine hydrochloride tablets. The dissolution condition was determined based on the "Guidelines on Specifications of Dissolution tests for Oral dosage forms" of Ministry of Food and Drug Safety (MFDS). The analytical method of HPLC was validated in specificity, linearity, precision and accuracy. Final dissolution test was performed with commercially available samples of 3 lots to establish specification. In addition, no difference was observed by the inter-laboratory evaluation. Dissolution specifications and conditions will be used for revising the monograph of acebrophylline capsules and bromhexine hydrochloride tablets in next supplement of KPC.

고시 수재 의약품 중 피라세탐 정 및 브롬화수소산페노테롤 정의 용출시험법 개발 (Development of Dissolution Testing Method for Piracetam Tablets and Fenoterol Hydrobromide Tablets in Korean Pharmaceutical Codex)

  • 김은정;이진하;박찬호;손경희;김인규;김동섭;사홍기;최후균
    • 약학회지
    • /
    • 제55권4호
    • /
    • pp.324-331
    • /
    • 2011
  • Although the dissolution test can serve as an effective tool for quality control and predictor of in vivo performance, there are a number of drugs with no established dissolution specifications in Korean Pharmaceutical Codex (KPC). Among those commercially available, Piracetam Tablets and Fenoterol hydrobromide Tablets were selected to develop the dissolution testing method. The dissolution condition was determined based on the "Guidelines on Specifications of Dissolution tests for Oral dosage forms" of Korea Food & Drug Administration (KFDA). The dissolution test for Piracetam Tablets was carried out under sink condition with distilled water as dissolution medium, paddle rotation speed at 50 rpm and medium volume of 900 ml. More than 80% of its label claim was released within 30 min. In case of Fenoterol hydrobromide Tablets, distilled water was also found to be suitable to ensure sink condition. The rotation speed of 50 rpm and 900 ml of dissolution medium were used to evaluate the dissolution profile. The dissolution rate of fenoterol hydrobromide was over 90% in 15 min. The HPLC analysis methods were validated in terms of accuracy, precision, specificity, linearity, quantitation limit and range. The results suggested that the analytical methods used are simple and suitable to measure the dissolution rate of piracetam and fenoterol hydrobromide. Therefore, the analysis methods could be utilized in setting dissolution specifications of Piracetam Tablets and Fenoterol hydrobromide Tablets in the revised version of KPC.